About 52,550 people are predicted to die from colorectal cancer in 2023, but screening can improve a patient’s chance at surviving it, according to a news release.
“So much work remains to educate people about gastrointestinal health and the importance of not delaying care,” John Popp, MD, AMSURG medical director said in the release. “Even as people are making up for colonoscopies missed during the early years of the COVID-19 pandemic, we know more people are being diagnosed younger and that many aren’t receiving their first screening at the recommended age of 45.”
AMSURG has more than 250 ASCs across 34 states.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.